At the news
? NEUTRALIMPACT 4/10 6-K filed Jun 30, 2026 at 14:00 ET
Sabesp and its subsidiary EMAE executed a Protocol and Justification for the merger of all EMAE shares into Sabesp, with an exchange ratio of 1.3195 Sabesp shares per EMAE share. The merger requires shareholder approval at EGMs scheduled for July 30, 2026, and is intended to simplify corporate structure and reduce costs. The transaction is modest in scale relative to Sabesp's $20.5B market cap and does not alter the company's fundamental financial trajectory, which showed declining net profit and rising debt in the prior fiscal year.
- Sabesp will merge all EMAE shares not already held, with EMAE becoming a wholly owned subsidiary.
- Exchange ratio: 1.3195 Sabesp common shares per EMAE common or preferred share.
- Total merger costs estimated at approximately BRL 4,450,000 (about $0.8M USD at current rates).
- EGMs for both companies set for July 30, 2026; no regulatory approvals required.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access